Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Evofem Biosciences: Q4 Earnings Insights

Evofem Biosciences (NASDAQ:EVFM) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
March 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Evofem Biosciences (NASDAQ:EVFM) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Evofem Biosciences missed estimated earnings by 43.48%, reporting an EPS of $-0.33 versus an estimate of $-0.23.

Revenue was up $3.40 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.19 which was followed by a 15.64% drop in the share price the next day.

 

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview For AdvanSix

By Benzinga Insights
Today, 7:08 AM
AdvanSix (NYSE:ASIX) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that AdvanSix will report an earnings per share (EPS) of $2.37.

ASIX